IL6 and COVID-19: In COVID-19 patients, elevated levels of IL-6 were associated with significant upregulation of P-selectin and PSGL-1, suggesting that IL-6 may exacerbate immune thrombosis by promoting platelet-leukocyte aggregation and endothelial activation (93).